Inspire Medical Systems Capital Expenditures (CapEx) Growth & History (INSP)
Inspire Medical Systems's capital expenditures (capex) was $38.5M for fiscal 2025.
View full Inspire Medical Systems company overviewInspire Medical Systems annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $38.5M | −$624,000 | −1.59% |
| 2024 | 2024-12-31 | $39.1M | $15.5M | +65.57% |
| 2023 | 2023-12-31 | $23.6M | $14.5M | +159.77% |
| 2022 | 2022-12-31 | $9.1M | $4.4M | +94.86% |
| 2021 | 2021-12-31 | $4.7M | $2.2M | +90.14% |
| 2020 | 2020-12-31 | $2.5M | −$284,000 | −10.37% |
| 2019 | 2019-12-31 | $2.7M | $2.5M | +995.60% |
| 2018 | 2018-12-31 | $250,000 | −$162,000 | −39.32% |
| 2017 | 2017-12-31 | $412,000 | — | — |
Inspire Medical Systems quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.2M | $163,000 | +1.81% |
| Q1 2026 | 2026-03-31 | $9.7M | $1.3M | +15.69% |
| Q4 2025 | 2025-12-31 | $10.7M | $3.6M | +51.64% |
| Q3 2025 | 2025-09-30 | $10.4M | $2.4M | +30.37% |
| Q2 2025 | 2025-06-30 | $9.0M | −$3.4M | −27.40% |
| Q1 2025 | 2025-03-31 | $8.4M | −$3.3M | −28.12% |
| Q4 2024 | 2024-12-31 | $7.0M | −$1.0M | −12.52% |
| Q3 2024 | 2024-09-30 | $8.0M | $1.0M | +14.58% |
| Q2 2024 | 2024-06-30 | $12.4M | $7.5M | +155.26% |
| Q1 2024 | 2024-03-31 | $11.7M | $7.9M | +211.64% |
| Q4 2023 | 2023-12-31 | $8.0M | $5.1M | +172.31% |
| Q3 2023 | 2023-09-30 | $7.0M | $3.5M | +98.97% |
| Q2 2023 | 2023-06-30 | $4.9M | $3.4M | +242.14% |
| Q1 2023 | 2023-03-31 | $3.8M | $2.5M | +208.89% |
| Q4 2022 | 2022-12-31 | $3.0M | $2.4M | +453.47% |
| Q3 2022 | 2022-09-30 | $3.5M | $2.4M | +205.13% |
| Q2 2022 | 2022-06-30 | $1.4M | −$244,000 | −14.67% |
| Q1 2022 | 2022-03-31 | $1.2M | −$106,000 | −8.02% |
| Q4 2021 | 2021-12-31 | $533,000 | −$71,000 | −11.75% |
| Q3 2021 | 2021-09-30 | $1.2M | −$64,000 | −5.27% |
| Q2 2021 | 2021-06-30 | $1.7M | $1.3M | +336.48% |
| Q1 2021 | 2021-03-31 | $1.3M | $1.1M | +418.04% |
| Q4 2020 | 2020-12-31 | $604,000 | $162,000 | +36.65% |
| Q3 2020 | 2020-09-30 | $1.2M | $151,000 | +14.19% |
| Q2 2020 | 2020-06-30 | $381,000 | −$577,000 | −60.23% |
| Q1 2020 | 2020-03-31 | $255,000 | −$20,000 | −7.27% |
| Q4 2019 | 2019-12-31 | $442,000 | $251,000 | +131.41% |
| Q3 2019 | 2019-09-30 | $1.1M | $1.1M | — |
| Q2 2019 | 2019-06-30 | $958,000 | $906,000 | +1742.31% |
| Q1 2019 | 2019-03-31 | $275,000 | $268,000 | +3828.57% |
| Q4 2018 | 2018-12-31 | $191,000 | $129,000 | +208.06% |
| Q3 2018 | 2018-09-30 | $0 | −$124,000 | — |
| Q2 2018 | 2018-06-30 | $52,000 | $32,000 | +160.00% |
| Q1 2018 | 2018-03-31 | $7,000 | −$199,000 | −96.60% |
| Q4 2017 | 2017-12-31 | $62,000 | — | — |
| Q3 2017 | 2017-09-30 | $124,000 | — | — |
| Q2 2017 | 2017-06-30 | $20,000 | — | — |
| Q1 2017 | 2017-03-31 | $206,000 | — | — |
Inspire Medical Systems capital expenditures (capex) trends
Over the last five fiscal years, Inspire Medical Systems's capital expenditures (capex) increased from $2.5M to $38.5M, a change of $36.0M. The latest reported quarter, Q2 2026, shows $9.2M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Inspire Medical Systems source filings ↗